FEB 07, 2020 6:07 AM PST

New diagnostic technology uses levitating proteins

WRITTEN BY: Tara Fernandez

Intrinsic biophysical properties of proteins hold valuable clues about how they function and their role in disease. Take, for example, one of the most commonly-used biological samples used to provide diagnostic answers: blood. A plethora of different proteins exist in blood plasma, from carrier proteins that transport hormones and vitamins, to globulins which serve as key components of the immune system.

Examining the 3-dimensional structures and physical properties of these blood proteins at high resolution would reveal a wealth of information, enabling the creation of specific proteomic profiles for different diseases. Unfortunately, however, this has remained outside the realm of possibility for researchers and clinicians due to the lack of appropriate analytical tools.

Morteza Mahmoudi, a professor at the Department of Radiology Nanoscience and Nano Biomedical Engineering at Michigan State University, has developed a new nanotechnology platform that can unveil previously hidden protein features with unprecedented resolution.

Here, magnetic nanoparticles are added to plasma samples, which naturally associate and bind to each other. This cocktail is then placed within a magnetic field, where the magnetic force causes proteins to “levitate”, separating them into bands based on their relative densities.

These bands form distinctive patterns that could provide vital indications on the health status of an individual. 

According to Mahmoudi, the next step in their research is to validate their platform for defining signature levitating protein profiles for cancer and multiple sclerosis (MS). At present, positively diagnosing MS involves using subjective measures, including monitoring the patient’s symptoms, behavior or response to initial treatments.

“There is no biomarker or MRI test to diagnose the different subtypes at the early stages. Correctly diagnosing the type of MS is critical, since it dictates which type of treatment is appropriate. We hope this MagLev method will give clinicians a technique to define the subtypes,” said Mahmoudi.

In addition, magnetic nanoparticles can also be used in other applications, including cancer therapies, genetic engineering and diagnosing bacterial infections.

 



Sources: Medgadget, Analytical Chemistry.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 29, 2020
Clinical & Molecular DX
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
OCT 29, 2020
More Frequent Trips to the Pediatrician Linked to a Future Autism Diagnosis
 
NOV 05, 2020
Clinical & Molecular DX
Digging DEEP into Metabolomic Space
NOV 05, 2020
Digging DEEP into Metabolomic Space
Metabolomics is an umbrella term encompassing lipidomics and the study of smaller polar metabolites.  As such, more ...
NOV 17, 2020
Clinical & Molecular DX
Tumor Stiffness Linked to Its Aggressiveness
NOV 17, 2020
Tumor Stiffness Linked to Its Aggressiveness
  As tumors grow, tiny areas at their cores are found to become stiff prior to metastasis, or the spread of cancer ...
NOV 25, 2020
Cancer
Using RNA to Diagnose HPV Associated Cancer
NOV 25, 2020
Using RNA to Diagnose HPV Associated Cancer
Diagnostic tools are critical to modern medicine. They might be less exciting than a good therapy or drug, but doctors a ...
DEC 03, 2020
Clinical & Molecular DX
Spit Contains Concussion Clues
DEC 03, 2020
Spit Contains Concussion Clues
Drowsiness, confusion, headaches, and sensitivity to light — it’s sometimes hard for doctors to spot the sig ...
JAN 01, 2021
Genetics & Genomics
Common Brain Disorder Has a Genetic Influence
JAN 01, 2021
Common Brain Disorder Has a Genetic Influence
It's thought that as many as one in one hundred people are born with a brain disorder known as Chiari 1 malformation, bu ...
Loading Comments...